From WCC 2022 | Nature Reviews Clinical Oncology
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:

Access through your institution Buy or subscribe In October 2022, delegates from 120 countries attended the World Cancer Congress (WCC) in Geneva. As the Union for International Cancer
Control (UICC) decided not to hold a virtual congress during the COVID-19 pandemic, for many attendees this was the first opportunity to reconnect since WCC 2018. Many presentations at WCC
2022 provided quantitative data demonstrating that the COVID-19 pandemic has challenged the ability of most health-care systems to provide adequate cancer management at every stage of the
disease. Well-documented examples include prevention (owing to disruption of HPV vaccination programmes), screening (with delays in several colorectal and lung national programmes) and
diagnosis (with a confirmed shift towards presentation at later disease stages for several cancer types). Other studies modelled the capacity of oncology services to adapt after the
pandemic. The main message is that recovery could be possible, at least to a certain extent, if all stakeholders are committed. This is a preview of subscription content, access via your
institution ACCESS OPTIONS Access through your institution Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription $32.99 / 30 days cancel
any time Learn more Subscribe to this journal Receive 12 print issues and online access $209.00 per year only $17.42 per issue Learn more Buy this article * Purchase on SpringerLink *
Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional
subscriptions * Read our FAQs * Contact customer support AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Nature Reviews Clinical Oncology http://www.nature.com/nrclinonc Diana Romero Authors *
Diana Romero View author publications You can also search for this author inPubMed Google Scholar CORRESPONDING AUTHOR Correspondence to Diana Romero. RIGHTS AND PERMISSIONS Reprints and
permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Romero, D. From WCC 2022. _Nat Rev Clin Oncol_ 20, 2 (2023). https://doi.org/10.1038/s41571-022-00706-1 Download citation * Published: 03
November 2022 * Issue Date: January 2023 * DOI: https://doi.org/10.1038/s41571-022-00706-1 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get
shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative